Pro Share Advisors LLC Infinity Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.49 - $1.2 $12,555 - $30,747	-25,623 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$0.85 - $2.4 $5,132 - $14,491	-6,038 Reduced 19.07%	25,623 $29,000
Q4 2021 Feb 08, 2022	BUY	$1.86 - $3.36 $38,027 - $68,695	20,445 Added 182.28%	31,661 $71,000
Q3 2021 Nov 12, 2021	SELL	$1.52 - $3.82 $17,467 - $43,899	-11,492 Reduced 50.61%	11,216 $38,000
Q2 2021 Aug 13, 2021	BUY	$2.66 - $3.47 $60,403 - $78,796	22,708 New	22,708 $68,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.